These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14170319)

  • 41. Purification of the nitrogenase proteins from Clostridium pasteurianum.
    Tso MY; Ljones T; Burris RH
    Biochim Biophys Acta; 1972 Jun; 267(3):600-4. PubMed ID: 5047139
    [No Abstract]   [Full Text] [Related]  

  • 42. 1H NMR studies on the oxidized ferredoxin from Clostridium pasteurianum.
    Ganadu ML; Bonomi F; Pagani S; Boelens R
    Biochem Int; 1992 Mar; 26(4):577-85. PubMed ID: 1610368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton magnetic resonance study of ferredoxin from Clostridium pasteurianum.
    Poe M; Phillips WD; McDonald CC; Lovenberg W
    Proc Natl Acad Sci U S A; 1970 Apr; 65(4):797-804. PubMed ID: 5266908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The separation of pyruvate-ferredoxin oxidoreductase from Clostridium pasteurianum into two enzymes catalyzing different reactions.
    Sauer FD; Bush RS; Stevenson IL
    Biochim Biophys Acta; 1976 Sep; 445(2):518-20. PubMed ID: 953041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cysteine ligand swapping on a deletable loop of the [2Fe-2S] ferredoxin from Clostridium pasteurianum.
    Golinelli MP; Akin LA; Crouse BR; Johnson MK; Meyer J
    Biochemistry; 1996 Jul; 35(27):8995-9002. PubMed ID: 8688437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [NAD and NADP ferredoxin reductase activities of acellular extracts of Clostridia of the butyric group].
    Petitdemange H; Bellanger M; Lambert D; Gay R
    C R Acad Hebd Seances Acad Sci D; 1971 Jun; 272(22):2840-3. PubMed ID: 4397524
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of the phosphoroclastic reaction of Clostridium pasteurianum in the reduction of metronidazole.
    Lockerby DL; Rabin HR; Laishley EJ
    Antimicrob Agents Chemother; 1985 May; 27(5):863-7. PubMed ID: 4015076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological activity of synthetic molybdenum-iron-sulphur, iron-sulphur and iron-selenium analogues of ferredoxin-type centres.
    Adams MW; Rao KK; Hall DO; Christou G; Garner CD
    Biochim Biophys Acta; 1980 Jan; 589(1):1-9. PubMed ID: 7356974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PHOSPHOROCLASTIC REACTIONS OF CLOSTRIDIUM NIGRIFICANS.
    AKAGI JM
    J Bacteriol; 1964 Sep; 88(3):813-4. PubMed ID: 14208530
    [No Abstract]   [Full Text] [Related]  

  • 50. N2 fixation by purified components of the N2-fixing system of Clostridium pasteurianum.
    Kennedy IR; Morris JA; Mortenson LE
    Biochim Biophys Acta; 1968 May; 153(4):777-86. PubMed ID: 5660383
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibitors of nitrogen fixation in extracts from Clostridium pasteurianum.
    Lockshin A; Burris RH
    Biochim Biophys Acta; 1965 Nov; 111(1):1-10. PubMed ID: 5867323
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the antigenicity of bacterial ferredoxins. I. The effect of modification of cysteinyl residues on the antigenicity of Clostridium pasteurianum ferredoxin.
    Nitz RM; Mitchell B; Gerwing J; Christensen J
    J Immunol; 1969 Aug; 103(2):319-23. PubMed ID: 5803788
    [No Abstract]   [Full Text] [Related]  

  • 53. Some structural features of cluster-coordinating cysteines of Clostridium pasteurianum ferredoxin are revealed by 2D TOCSY 1H NMR on the oxidized protein.
    Acquotti D; Bonomi F; Brocca P; Ganadu ML; Pagani S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):591-5. PubMed ID: 8037766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and characteristics of flavodoxin from nitrogen-fixing Clostridium pasteurianum.
    Knight E; Hardy RW
    J Biol Chem; 1966 Jun; 241(12):2752-6. PubMed ID: 5912352
    [No Abstract]   [Full Text] [Related]  

  • 55. Some aspects of hydrogenase activity and nitrogen fixation in Azotobacter spp and in Clostridium pasteurianum.
    NICHOLAS DJ; FISHER DJ; REDMOND WJ; WRIGHT MA
    J Gen Microbiol; 1960 Feb; 22():191-205. PubMed ID: 14426896
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of [4Fe-4S]2+, [4Fe-4Se]2+ and hybrid (S, Se) clusters in Clostridium pasteurianum ferredoxin. A resonance Raman study.
    Moulis JM; Meyer J; Lutz M
    Biochem J; 1984 May; 219(3):829-32. PubMed ID: 6743247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extensive ligand rearrangements around the [2Fe-2S] cluster of Clostridium pasteurianum ferredoxin.
    Golinelli MP; Chatelet C; Duin EC; Johnson MK; Meyer J
    Biochemistry; 1998 Jul; 37(29):10429-37. PubMed ID: 9671512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological studies on peptides from the haptenic C-terminal octapeptide of Clostridium pasteurianum ferredoxin.
    Mitchell B; Levy JG
    Biochemistry; 1970 Jul; 9(14):2762-6. PubMed ID: 5459532
    [No Abstract]   [Full Text] [Related]  

  • 59. Analysis of the high-spin states of the 2[4Fe-4Se]+ ferredoxin from Clostridium pasteurianum by Mössbauer spectroscopy.
    Auric P; Gaillard J; Meyer J; Moulis JM
    Biochem J; 1987 Mar; 242(2):525-30. PubMed ID: 3593266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterologous overproduction of 2[4Fe4S]- and [2Fe2S]-type clostridial ferredoxins and [2Fe2S]-type agrobacterial ferredoxin.
    Huang H; Hu L; Yu W; Li H; Tao F; Xie H; Wang S
    Protein Expr Purif; 2016 May; 121():1-8. PubMed ID: 26748213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.